Showing results (101-110 of 436) with videos related to

Sort By:
Pageof 44
Arthritis and Rheumatism|October 31, 2007
Increased expression of discoidin domain receptor 2 is linked to the degree of cartilage damage in human knee joints: a potential role in osteoarthritis pathogenesisIlse-Gerlinde Sunk, Klaus Bobacz, Jochen G Hofstaetter, et al.
Arthritis Research & Therapy|November 30, 2013
Patient education, disease activity and physical function: can we be more targeted? A cross sectional study among people with rheumatoid arthritis, psoriatic arthritis and hand osteoarthritisRăzvan G Drăgoi, Mwidimi Ndosi, Martina Sadlonova, et al.
Rheumatology and Therapy|February 27, 2025
Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT TrialsLars-Erik Kristensen, Dennis McGonagle, Martin Rudwaleit, et al.
Digestive Diseases and Sciences|January 16, 2023
Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical RemissionNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Digestion|October 29, 2003
An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's diseaseClemens Dejaco, Conny Lichtenberger, Wolfgang Miehsler, et al.
World Journal of Gastroenterology|September 30, 2006
Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's diseaseGottfried Novacek, Wolfgang Miehsler, Julia Palkovits, et al.
The American Journal of Gastroenterology|September 6, 2022
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY StudyNeeraj Narula, Emily C L Wong, John K Marshall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2025
Week 12 Reduction in MM-SES-CD is Predictive of Delayed Response to Upadacitinib in Crohn's diseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Digestive Diseases and Sciences|February 19, 2026
Impact of Comorbid Psoriasis on the Efficacy of Ustekinumab and Mirikizumab in Inflammatory Bowel Disease: A Post-hoc Analysis of UNITI, SEAVUE, and LUCENTEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Bulletin of the NYU Hospital for Joint Diseases|July 17, 2010
Progress toward the development of a new definition of remission in rheumatoid arthritisMaarten Boers, David T Felson, George Wells, et al.
Pageof 44